Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase NA 2Phase 1 2Phase 3 1Phase 1/2 1

Status

Unknown 1

Sponsor Class

OTHER 34INDUSTRY 2OTHER_GOV 1NIH 1NETWORK 1FED 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1

Conditions

Prediabetic State 1Obesity 1Neoplasms 1Diabetes Mellitus, Type 2 1Diabetes Mellitus 1

Interventions

Cyclophosphamide 109Radiotherapy 106Fluorouracil 76Doxorubicin 74Carboplatin 71Etoposide 67Cisplatin 67Vincristine 66Paclitaxel 58Chemotherapy, Adjuvant 53Leucovorin 47Specimen Handling 43Cytarabine 42Magnetic Resonance Spectroscopy 38Methotrexate 37Dexamethasone 33Taxes 31Bevacizumab 31Peripheral Blood Stem Cell Transplantation 30Gemcitabine 30Filgrastim 30Docetaxel 30Tamoxifen 28Melphalan 28Immunoglobulin G 25Epirubicin 25Disulfides 25Oxaliplatin 24Daunorubicin 24Prednisone 23

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × NIH × Metformin × Clear all
NCT00038727 2021-12-28

DPPOS

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Phase 3 Unknown
2,779 enrolled 16 charts
Other

Diabetes Mellitus, Diabetes Mellitus, Type 2, Neoplasms, Obesity, Prediabetic State

Data powered by HemOnc (CC BY 4.0) Colophon âš¡